Spinocerebellar ataxia 7 (SCA7)

Cytogenetic and Genome Research

Volumn 100, Issue 1-4, 2003, Pages 154-163

  Lebre, A S ^a   Brice, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 7; POLYGLUTAMINE; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; AUTOSOMAL DOMINANT DISORDER; CENTRAL NERVOUS SYSTEM; CEREBELLAR ATAXIA; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE TRANSMISSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

BRAIN; DISEASE PROGRESSION; GENOTYPE; NERVE TISSUE PROTEINS; PHENOTYPE; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

ATAXIA;

EID: 0344100065     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072850     Document Type: Review

References (71)

1. Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG: Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype. Exp Eye Res 74:737-745 (2002).
2. Andrew SE, Goldberg YP, Hayden MR: Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum molec Genet 6 2005-2010 (1997).
3. Babovic-Vuksanovic D, Snow K, Patterson MC, Michels VV: Spinocerebellar ataxia type 2 (SCA2) in an infant with extreme CAG repeat expansion. Am J med Genet 79:383-387 (1998).
4. Benomar A, Le Guern E, Dürr A, Ouhabi H, Stevanin G, Yahyaoui M, Chkili T, Agid Y, Brice A: Autosomal-dominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type I. Ann Neurol 35:439-444 (1994).
5. Benomar A, Krols L, Stevanin G, Cancel G, Le Guern E, David G, Ouhabi H, Martin JJ, Dürr A, Zaim A, Ravise N, Busque C, Penet C, Van Regemorter N, Weissenbach J, Yahyaoui M, Chkili T, Agid Y, Van Broeckhoven C, Brice A: The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12→ p21.1. Nature Genet 10:84-88 (1995).
6. Benton CS, de Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY: Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology 51:1081-1086 (1998).
7. Cancel G, Dürr A, Didierjean O, Imbert G, Bürk K, Lezin A, Belal S, Benomar A, Abada-Bendib M, Vial C, Guimaraes J, Chneiweiss H, Stevanin G, Yvert G, Abbas N, Saudou F, Lebre A-S, Yahyaoui M, Hentati F, Vernant J-C, Klockgether T, Mandel J-L, Agid Y, Brice A: Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum molec Genet 6 709-715 (1997).
8. Cancel G, Duyckaerts C, Holmberg M, Zander C, Yvert G, Lebre AS, Ruberg M, Faucheux B, Agid Y, Hirsch E, Brice A: Distribution of ataxin-7 in normal human brain and retina. Brain 123:2519-2530 (2000).
9. Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S: Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci 24:182-188 (2001).
10. Cooper JK, Schilling G, Peters MF, Herring WJ, Sharp AH, Kaminsky Z, Masone J, Khan FA, Delanoy M, Borchelt DR, Dawson VL, Dawson TM, Ross CA: Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum molec Genet 7:783-790 (1998).
11. David G, Giunti P, Abbas N, Coullin P, Stevanin G, Horta W, Gemmill R, Weissenbach J, Wood N, Cunha S, Drabkin H, Harding AE, Agid Y, Brice A: The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12→ p13: genetic and physical mapping of the SCA7 locus. Am J hum Genet 59:1328-1336 (1996).
12. David G, Abbas N, Stevanin G, Dürr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel J-L, Brice A: Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet 17:65-70 (1997).
13. David G, Dürr A, Stevanin G, Cancel G, Abbas N, Benomar A, Belal S, Lebre A-S, Abada-Bendib M, Grid D, Holmberg M, Yahyaoui M, Hentati F, Chkili T, Agid Y, Brice A: Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum molec Genet 7:165-170 (1998a).
14. David G, Abbas N, Durr A, Stevanin G, Cancel G, Yvert G, Imbert G, Saudou F, Mandel J-L, Agid Y, Brice A: Autosomal dominant cerebellar ataxia with macular dystrophy (SCA7) is caused by a highly unstable CAG repeat expansion, in Wells RD, Warren ST (eds): Genetic instabilities and hereditary neurological diseases, pp 273-282 (Academic Press, San Diego 1998b).
15. Del-Favero J, Krols L, Michalik A, Theuns J, Löfgren A, Goossens D, Wehnert A, van den Bossche D, van Zand K, Backhovens H, Van Regenmorter N, Martin JJ, Van Broeckhoven C: Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. Hum molec Genet 7:177-186 (1998).
16. Einum DD, Townsend JJ, Ptacek LJ, Fu YH: Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients. Neurogenetics 3:83-90 (2001).
17. Ellerby LM, Andrusiak RL, Wellington CL, Hackam AS, Propp SS, Wood JD, Sharp AH, Margolis RL, Ross CA, Salvesen GS, Hayden MR, Bredesen DE: Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J biol Chem 274:8730-8736 (1999).
18. Enevoldson TP, Sanders MD, Harding AE: Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy A clinical and genetic study of eight families. Brain 117:445-460 (1994).
19. Froment J, Bonnet P, Colrat A: Heredo-dégénérations rétinienne et spino-cérébelleuses: variantes ophtalmoscopiques et neurologiques présentées par trois générations successives. J Med Lyon 22:153-163 (1937).
20. Garden GA, Libby RT, Fu YH, Kinoshita Y, Huang J, Possin DE, Smith AC, Martinez RA, Fine GC, Grote SK, Ware CB, Einum DD, Morrison RS, Ptacek LJ, Sopher BL, La Spada AR: Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J Neurosci 22:4897-4905 (2002).
21. Giunti P, Stevanin G, Worth P, David G, Brice A, Wood NW: Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation. Am J hum Genet 64:1594-1603 (1999).
22. Gouw LG, Digre KB, Harris CP, Haines JH, Ptacek LJ: Autosomal dominant cerebellar ataxia with retinal degeneration: clinical neuropathologic and genetic analysis of a large kindred. Neurology 44:1441-1447 (1994).
23. Gouw LG, Kaplan CD, Haines JH, Digre KB, Rutledge SL, Matilla A, Leppert M, Zoghbi HY, Ptacek LJ: Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nature Genet 10:89-93 (1995).
24. Gouw LG,Castaneda MA, McKenna CK, Digre KB, Pulst SM, Perlman S, Lee MS, Gomez C, Fischbeck K, Gagnon D, Storey E, Bird T, Jeri FR, Ptacek LJ: Analysis of the dynamic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission Hum molec Genet 7:525-532 (1998).
25. Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, Sterne-Marr R, Hosey MM, Benovic JL: Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin beta 2-adrenergic and m2 muscarinic cholinergic receptors. J biol Chem 270:720-731 (1995).
26. Harding AE: The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families including descendants of the "the Drew family of Walworth". Brain 105:1-28 (1982).
27. Harding AE: Clinical features and classification of inherited ataxias. Adv Neurol 61:1-14 (1993).
28. Holmberg M, Johansson J, Forsgren L, Heijbel J, Sandgren O, Holmgren G. Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12→ p21.1. Hum molec Genet 4:1441-1445 (1995).
29. Holmberg M, Duyckaerts C, Durr A, Cancel G, Gourfinkel-An I, Damier P, Faucheux B, Trottier Y, Hirsch EC, Agid Y, Brice A: Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum molec Genet 7:913-918 (1998).
30. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A: Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet 13:196-202 (1996).
31. Jöbsis GJ, Weber JW, Barth PG, Keizers H, Baas F, van Schooneveld MJ, van Hilten JJ, Troost D, Geesink HH, Bolhuis PA: Autosomal dominant cerebellar ataxia with retinal degeneration (ADCA II): clinical and neuropathological findings in two pedigrees and genetic linkage to 3p12→ p21.1. J Neurol Neurosurg Psychiatry 62:367-371 (1997).
32. Johansson J, Forsgren L, Sandgren O, Brice A, Holmgren G, Holmberg M: Expanded CAG repeat in Swedish Spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation. Hum molec Genet 7:171-176 (1998).
33. Jonasson J, Strom AL, Hart P, Brannstrom T, Forsgren L, Holmberg M: Expression of ataxin-7 in CNS and non-CNS tissue of normal and SCA7 individuals. Acta Neuropathol (Berl) 104:29-37 (2002).
34. Kaytor MD, Duvick LA, Skinner PJ, Koob MD, Ranum LP, Orr HT: Nuclear localization of the spino-cerebellar ataxia type 7 protein ataxin-7. Hum molec Genet 8:1657-1664 (1999).
35. Konigsmark BW, Weiner LP: The olivopontocerebellar atrophies: a review. Medicine (Baltimore) 49:227-241 (1970).
36. Koob MD, Benzow KA, Bird TD, Day JW, Moseley ML, Ranum LPW: Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. Nature Genet 18:72-75 (1998).
37. Krols L, Martin JJ, David G, Van Regemorter N, Benomar A, Lofgren A, Stevanin G, Durr A, Brice A, Van Broeckhoven C: Refinement of the locus for autosomal dominant cerebellar ataxia type II to chromosome 3p21.1→ p14.1. Hum Genet 99:225-232 (1997).
38. La Spada AR, Fu Y, Sopher BL, Libby RT, Wang X, Li LY, Einum DD, Huang J, Possin DE, Smith AC, Martinez RA, Koszdin KL, Treuting PM, Ware CB, Hurley JB, Ptacek LJ, Chen S: Polyglutamine-expanded ataxin-7 antagonizes crx function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31:913-927 (2001).
39. Lebre AS, Jamot L, Takahashi J, Spassky N, Leprince C, Ravise N, Zander C, Fujigasaki H, Kussel-Andermann P, Duyckaerts C, Camonis JH, Brice A: Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions. Hum molec Genet 10:1201-1213 (2001).
40. Lindblad K, Savontaus ML, Stevanin G, Holmberg M, Digre K, Zander C, Ehrsson H, David G, Benomar A, Nikoskelainen E, Trottier Y, Holmgren G, Pta-cek LJ, Anttinen A, Brice A, Schalling M: An expanded CAG repeat sequence in spinocerebellar ataxia type 7. Genome Res 6:965-971 (1996).
41. Lindenberg KS, Yvert G, Muller K, Landwehrmeyer GB: Expression analysis of ataxin-7 mRNA and protein in human brain: evidence for a widespread distribution and focal protein accumulation. Brain Pathol 10:385-394 (2000).
42. Luthi-Carter R,Strand AD, Hanson SA, Kooperberg C, Schilling G, La Spada AR, Merry DE, Young AB, Ross CA, Borchelt DR, Olson JM: Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum molec Genet 11:1927-1937 (2002).
43. Lyoo CH, Hun K, Choi YC, Lee SC, Stevanin G, David G, Brice A, Lee MS: CAG repeat expansion in the SCA7 gene in Korean families presenting with ADCA type II. J Korean Neurol Assoc 16:341-352 (1998).
44. Martin JJ, Van Regemorter N, Krols L, Brucher JM, de Barsy T, Szliwowski H, Evrard P, Ceuterick C, Tassignon MJ, Smet-Dieleman H, Hayez-Delatte F, Willems PJ, Van Broeckhoven C: On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol (Berl) 88:277-286 (1994).
45. Martin J, Van Regemorter N, Del-Favero J, Lofgren A, Van Broeckhoven C: Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family. J Neurol Sci 168:37-46 (1999).
46. Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, McCutcheon K, Singaraja R, Kazemi-Esfarjani P, Devon R, Kim SU, Bredesen DE, Tufaro F, Hayden MR: Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet 18:150-154 (1998).
47. Matilla A, Gorbea C, Einum DD, Townsend T, Michalik A, van Broeckhoven C, Jensen CC, Murphy KJ, Ptacek LJ, Fu Y-H: Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex. Hum mol Genet 10:2821-2831 (2001).
48. Mauger C, Del-Favero J, Ceuterick C, Lubke U, Van Broeckhoven C, Martin J: Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody. Brain Res Mol Brain Res 74:35-43 (1999).
49. Monckton DG, Cayuela ML, Gould FK, Brock GJ, Silva R, Ashizawa T: Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum molec Genet 8:2473-2478 (1999).
50. Mushegian AR, Vishnivetskiy SA, Gurevich VV: Conserved phosphoprotein interaction motif is functionally interchangeable between ataxin-7 and arrestins. Biochemistry 39:6809-6813 (2000).
51. Nardacchione A, Orsi L, Brusco A, Franco A, Grosso E, Dragone E, Mortara P, Schiffer D, De Marchi M: Definition of the smallest pathological CAG expansion in SCA7. Clin Genet 56:232-234 (1999).
52. Neetens A, Martin JJ, Libert J, Van Den Ende P: Autosomal dominant cone-dystrophy-cerebellar atrophy (ADCoCA) (modified ADCA Harding II). Neuro-ophthalmology 10:261-275 (1990).
53. Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE, Yuan J, Penney JB, Young AB, Cha JH, Friedlander RM: Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399:263-267 (1999).
54. Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR: A novel multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol Cell Biol 18:872-879 (1998).
55. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Bian-calana V, Cassiman JJ, Chotai K, Connarty M, Craufurd D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Jackson A, Kaplan JC, Losekoot M, MacMillan JC, Trottier Y, Novelleto A, Simpson SA, Theilman J, Whittak-er JL, Folstein SE, Ross CA, Hayden MR: Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J hum Genet 59:16-22 (1996).
56. Schalling M, Hudson TJ, Buetow KH, Housman DE: Direct detection of novel expanded trinucleotide repeats in the human genome. Nature Genet 4:135-139 (1993).
57. Schols L, Amoiridis G, Buttner T, Przuntek H, Epplen JT, Riess O: Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 42:924-932 (1997).
58. Stevanin G, Trottier Y, Cancel G, Dürr A, David G, Didierjean O, Bürk K, Imbert G, Saudou F, Abada-Bendib M, Gourfinkel-An I, Benomar A, Abbas N, Klockgether T, Grid D, Agid Y, Mandel J-L, Brice A: Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Hum molec Genet 5:1887-1892 (1996).
59. Stevanin G, Giunti P, Belal GDS, Durr A, Ruberg M, Wood N, Brice A: De novo expansion of intermediate alleles in spinocerebellar ataxia 7. Hum molec Genet 7:1809-1813 (1998).
60. Stevanin G, David G, Durr A, Giunti P, Benomar A, Abada-Bendib M, Lee MS, Agid Y, Brice A: Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers including an in-tragenic polymorphism (G3145TG/A3145TG). Eur J hum Genet 7:889-896 (1999).
61. Stevanin G, Durr A, Brice A: Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J hum Genet 8:4-18 (2000a).
62. Stevanin G, Durr A, Brice A: Spinocerebellar ataxia 7 (SCA7), in Klockgether T (ed): Handbook of ataxia disorders (Marcel Dekker Inc, New York 2000b).
63. Strom AL, Jonasson J, Hart P, Brannstrom T, Forsgren L, Holmberg M: Cloning and expression analysis of the murine homolog of the spinocerebellar ataxia type 7 (SCA7) gene. Gene 285:91-99 (2002).
64. Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Durr A, Lebre AS, Yvert G, Trottier Y, The H, Hauw JJ, Duyckaerts C, Brice A: Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain 125:1534-1543 (2002).
65. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Laszlo T, Agid Y, Brice A, Mandel J-L: Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378:403-406 (1995).
66. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross CA, Nicholson DW, Bredesen DE, Hayden MR: Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J biol Chem 273:9158-9167 (1998).
67. World Federation of Neurology Research Group on Huntington's Chorea: International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea Guidelines for the molecular genetics predictive test in Huntington's disease. J med Genet 31:555-559 (1994).
68. Yvert G, Lindenberg KS, Picaud S, Landwehrmeyer GB, Sahel JA, Mandel JL: Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum molec Genet 9:2491-2506 (2000).
69. Yvert G, Lindenberg KS, Devys D, Helmlinger D, Landwehrmeyer GB, Mandel JL: SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types. Hum molec Genet 10:1679-1692 (2001).
70. Zander C, Takahashi J, El Hachimi KH, Fujigasaki H, Albanese V, Lebre AS, Stevanin G, Duyckaerts C, Brice A: Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. Hum molec Genet 10 2569-2579 (2001).
71. Zoghbi HY, Orr HT: Glutamine repeats and neurode-generation. A Rev Neurosci 23:217-247 (2000).